164 related articles for article (PubMed ID: 15031882)
1. Ephedra banned.
Cockey CD
AWHONN Lifelines; 2004; 8(1):19-25. PubMed ID: 15031882
[No Abstract] [Full Text] [Related]
2. Medicine. Ephedra--scientific evidence versus money/politics.
Wolfe SM
Science; 2003 Apr; 300(5618):437. PubMed ID: 12702860
[No Abstract] [Full Text] [Related]
3. FDA v. ephedra: is it time to lift the ban?
Pyle KR
Food Drug Law J; 2006; 61(4):701-51. PubMed ID: 17180770
[No Abstract] [Full Text] [Related]
4. Adverse events associated with supplements containing ephedra alkaloids.
Geiger JD
Clin J Sport Med; 2002 Jul; 12(4):263. PubMed ID: 12150162
[No Abstract] [Full Text] [Related]
5. Developments in food and drug law.
Masoudi GF
Food Drug Law J; 2005; 60(2):107-16. PubMed ID: 16097088
[No Abstract] [Full Text] [Related]
6. The need for regulation of dietary supplements--lessons from ephedra.
Fontanarosa PB; Rennie D; DeAngelis CD
JAMA; 2003 Mar; 289(12):1568-70. PubMed ID: 12672775
[No Abstract] [Full Text] [Related]
7. Working to get ephedra banned.
Consum Rep; 2003 Feb; 68(2):6. PubMed ID: 12516584
[No Abstract] [Full Text] [Related]
8. Time to ban ephedra--now.
Guharoy R; Noviasky JA
Am J Health Syst Pharm; 2003 Aug; 60(15):1580-2. PubMed ID: 12951759
[No Abstract] [Full Text] [Related]
9. Ergogenic aids: an update on ephedra.
Keisler BD; Hosey RG
Curr Sports Med Rep; 2005 Aug; 4(4):231-5. PubMed ID: 16004835
[TBL] [Abstract][Full Text] [Related]
10. The relative safety of ephedra compared with other herbal products.
Kalman DS; Antonio J; Kreider RB
Ann Intern Med; 2003 Jun; 138(12):1006; author reply 1006-7. PubMed ID: 12809464
[No Abstract] [Full Text] [Related]
11. Natural-born killers.
Mandavilli A
Nat Med; 2003 Jun; 9(6):634-5. PubMed ID: 12778149
[No Abstract] [Full Text] [Related]
12. More evidence supporting the ban of ephedra dietary supplements.
Chavez ML
Ann Pharmacother; 2004 May; 38(5):895-7. PubMed ID: 15044656
[No Abstract] [Full Text] [Related]
13. NEJM study detailing the causative link between ephedra-containing supplements and adverse cardiovascular and neurovascular.
Wolf L; Wolf M; Snavely M; Staudenmeier JJ;
Mil Med; 2002 Sep; 167(9):ii. PubMed ID: 12363175
[No Abstract] [Full Text] [Related]
14. HHS to study ephedra, step up enforcement against illegal marketing.
FDA Consum; 2002; 36(5):3. PubMed ID: 12412534
[No Abstract] [Full Text] [Related]
15. Ephedra ban: no shortage of reasons.
Rados C
FDA Consum; 2004; 38(2):6-7. PubMed ID: 15101356
[TBL] [Abstract][Full Text] [Related]
16. Ephedra-free is not danger-free.
Marcus DM; Grollman AP
Science; 2003 Sep; 301(5640):1669-71; author reply 1669-71. PubMed ID: 14500960
[No Abstract] [Full Text] [Related]
17. FDA to ban sales of dietary supplements containing ephedra.
Ling AM
J Law Med Ethics; 2004; 32(1):184-6. PubMed ID: 15152444
[No Abstract] [Full Text] [Related]
18. Medicolegal issues and ergogenic aids: trade, tragedy, and public safety, the example of ephedra and the Dietary Supplement Health and Education Act.
Phillips GC
Curr Sports Med Rep; 2004 Aug; 3(4):224-8. PubMed ID: 15231227
[TBL] [Abstract][Full Text] [Related]
19. [Ephedra products from the Internet: dangerous herb].
Kaulen H
Dtsch Med Wochenschr; 2004 Feb; 129(9):420. PubMed ID: 15017985
[No Abstract] [Full Text] [Related]
20. Cardiovascular effects of ephedra.
Ness J
JAMA; 2004 Apr; 291(13):1560; author reply 1560-1. PubMed ID: 15069037
[No Abstract] [Full Text] [Related]
[Next] [New Search]
